The latest market report published by Credence
Research, Inc. “Interventional
Cardiology and Peripheral Vascular Devices Market By Product (Angioplasty Stents, Angioplasty
Balloon Catheter, Guidewires, Vascular Closure Devices, Peripheral Embolic
Protection Devices, Atherectomy Devices, Endovascular Stent Grafts, Vascular
Grafts, Thrombectomy Devices, Inferior Vena Cava Filter) - Growth, Future
Prospects and Competitive Analysis, 2017-2025,” the worldwide market for
interventional cardiology and peripheral vascular devices was valued at US$
14.53 billion in 2016 and increased to CAGR by 8.8%.
Browse
the full report at https://www.credenceresearch.com/report/interventional-cardiology-peripheral-vascular-devices-market
Market
Insights
Interventional cardiology and peripheral vascular
therapy is a preferred option to traditional open surgery for cardiovascular
disease therapy. Interventional methods are gaining recognition in the medical
fraternity for the therapy of cardiac illnesses and peripheral vascular
diseases in order to be secure and effective in terms of therapy outcomes. The
market for interventional cardiology and peripheral vascular devices is
anticipated to see steady growth owing to increased private satisfaction among
patients with coronary heart illness and peripheral vascular disorders. The
future interventional strategy will continue to grow as fresh techniques take
over open surgery.
Global interventional cardiology and peripheral
vascular device market growth is fuelled by rising cardiovascular disease and
ensuing elevated mortality rates worldwide since heart disease caused 633,000
deaths among Americans in 2015, according to information reported by the
National Center for Health Statistics. Peripheral arterial disease affects more
than 10 million patients, causing further discomfort and severe complications.
Sedentary lifestyles with fat-rich dietary habits, increased consumption of
tobacco and alcohol, and stress act as a trigger for cardiovascular disease. In
addition to these, two other significant risk factors for cardiovascular diseases
are diabetes and obesity, which are also on the increase and are likely to
increase market growth. The adoption of changing technology in healthcare
centres, an growing amount of cardiac catheterization labs and an growing fund
for continuing cardiovascular studies have a beneficial effect on the
development of the industry.
Based on the type of interventional cardiology and
peripheral vascular devices, the market was dominated by angioplasty stents and
angioplasty catheters in 2016. Increasing proclivity to minimally invasive
surgical processes, the application of angioplasty stents and catheters in
cardiac processes is accelerating. This functions as the main driving force for
profitable market growth owing to reduced complications and quicker recovery.
On the basis of regional segmentation, North America
leads the global interventional cardiology and peripheral vascular devices
market owing to advanced healthcare infrastructure, increasing healthcare
expenditure in order to develop innovative treatment and growing health
awareness in people. Rising prevalence of cardiovascular disorders owing to
constantly changing lifestyle and increasing geriatric population primarily
drive the interventional cardiology and peripheral vascular devices market.
Gradually rising number of percutaneous coronary intervention (PCI) centers in
the United States also plays as key driver of interventional cardiology and
peripheral vascular devices market. The interventional cardiology and
peripheral vascular devices market in Asia Pacific region is expected to
witness substantial growth due to developing economies and rising initiatives
for betterment of health and rising health consciousness.
Download
Free PDF Sample Request: https://www.credenceresearch.com/sample-request/58895
Market Competition Assessment:
The major industry players of interventional
cardiology and peripheral vascular devices market having interventional
cardiology and peripheral vascular devices market includes Cook Medical, Inc.,
Boston Scientific Corporation, Cardinal Health, Inc., St. Jude Medical, Abbott
Laboratories, C. R. Bard, Inc., Medtronic plc., Edwards Lifesciences
Corporation, Terumo Corporation, B. Braun Melsungen AG, Baxter International
Inc., 3M Company, and other notable players.
Key Market Movements:
- Increasing
geriatric population, growing prevalence of cardiovascular disease, rising
focus into treatment with lesser complication and improved outcomes,
inclining trend towards minimally invasive procedure acted as major
drivers of the interventional cardiology and peripheral vascular devices
market.
- Conventional
treatment and medication are considered to act as threats for
interventional cardiology and peripheral vascular devices market.
By
Product Type
- Angioplasty
Stents
- Angioplasty
Balloon Catheter
- Guidewires
- Vascular
Closure Devices
- Peripheral
Embolic Protection Devices
- Atherectomy
Devices
- Endovascular
Stent Grafts
- Vascular
Grafts
- Thrombectomy
Devices
- Inferior
Vena Cava Filter
- Others
(Hemodynamic Flow Alteration Devices, Plaque Modification Devices, Balloon
Inflation Devices)
By Geography Segment (2017–2027; US$ Bn)
- North
America
- Europe
- Asia
Pacific (APAC)
- Middle
East & Africa (MEA)
- Latin
America
No comments:
Post a Comment